Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
abrogate, absent, activeZometa, adenoma, advent, aeruginosa, affixing, African, agomelatine, agonistForadil, albumin, aldesleukin, aldosterone, alliance, ambition, Amgen, andCertican, andDiovan, andExjade, andin, andLucentisfor, andMycograb, andNIGHT, andRasilez, andResource, andSebivo, andVisudyne, andZaditen, Ankleshwar, Annex, annum, antiangiogenic, anticholinergic, antigen, areExelon, arid, arterial, ascribe, Asmanex, assay, asterisk, asTyzeka, asZelmac, attenuated, Attn, audio, Aurograb, automated, avian, background, bacteremia, belonged, belonging, biodegradable, biographical, BLA, Bluebay, branch, broadly, Candida, carcinoma, cardiometabolic, Cartago, CBER, cellular, CF, chemotherapeutic, childhood, chord, chromosome, circulating, circumvent, cKIT, Clariant, CLL, cohort, Colombia, combiningProleukin, complementaryAmendment, compliant, compromised, confer, conference, confirmedFemara, conflict, conjugation, constrict, contrary, contributory, CooperVision, cord, corruption, corticosteroid, counsel, cow, Crucell, Cubicin, Cubist, cyclic, cystic, daptomycin, DB, deal, dealt, declaratory, decoding, deferoxamine, dehydrogenase, Democratic, demographic, Dept, dermatofibrosarcoma, diagnostic, dihydropyridine, diphtheria, discretionary, diverging, DNA, donated, dovitinib, drugsDiovan, Duesseldorf, edge, effectsin, eligen, Emeryville, Emisphere, endorse, enzymatic, EpsteinAmerican, ER, EVA, Everett, evolution, evolving, Exploratory, expressly, Fairfax, fallen, FD, felt, female, FGF, fight, fighting, filer, fill, Fitch, Flagyl, focussed, footnote, forLamisil, forTOBI, fromDiovan, fromForadil, ft, fusion, garage, gastroenteropancreatic, gender, gene, Genussscheine, Ghana, glioma, GMP, graph, ground, hardship, HBV, HCBA, HCV, heighten, hemihydrate, hemisphere, hereinbefore, heritage, HHS, HIV, Holcim, Holly, host, hypereosinophilic, IAP, ICF, ICMA, IDIX, immunoassay, immunogenicity, immunotherapy, ImVision, includeFemara, includeTasigna, ineffective, inFemara, Intercell, internationally, introducedLil, invasive, inVisudyne, irregularity, irrevocably, ISIN, isTekturna, itsFluvirin, iur, IVD, Joerg, Jolla, justified, Kehoe, Koch, Kreisschreiben, Laboratoire, lactate, launchExforge, launchOmnitrope, laying, LDH, Lenz, lesser, licensor, Licensure, lifelong, lifestyle, Lifetech, linesin, Liverpool, lotrafilcon, mad, magnitude, mailbox, Malta, mandatorily, mapping, Marburg, markedly, medicineLamisilwill, medicinesCibacen, medium, melanoma, memory, meningococcal, meritocracy, message, Metronidazole, Metropolol, Michael, misconduct, mishandling, mixture, modulator, Momenta, MRSA, MSWPI, Muckle, mutant, mutated, Mycograb, naive, namesCombipatch, NAT, nausea, Neurosdystrophic, NeuTec, NeuTech, Nile, nonadvisory, nonfinancial, nonqualified, nonvoting, northern, notwithstanding, Novogyne, Nr, nucleic, nucleoside, Nuvo, ODGU, ofAclasta, ofCubicin, ofGalvuswith, ofTasigna, ofXolairfor, Omnitrope, Ondansetron, OPTIXandNIGHT, Organizationally, oriented, overdraft, overdue, overseen, overtime, pandemic, pdf, PDGF, peak, pentavalent, photodynamic, pICT, PKC, plagued, Planta, pledged, pneumonia, poliglumex, polyglutamate, polymerase, Postretirement, predominant, prequalification, prerequisite, Prime, privileged, PROCLEIX, productLamisil, productsDiovan, productsExelon, productTrileptal, profound, Proleukin, Proteome, protocol, purified, ranimizumab, ratified, reaction, redesigned, referenced, Reinhardt, relocating, Rembrandt, renovated, repositioned, resubmitPrexige, revolutionary, RHHBY, ribavirin, rituximab, RNA, RO, ROG, Rosia, Rosneft, roughly, Rudolstadt, Saarbruecken, Sabin, Sanitation, SCandVoltaren, SchmidtAmerican, Schweizerische, screen, screening, seize, sensitizerStarlix, sensory, Servier, sharp, shipped, shipping, Siena, skilled, slide, SMI, solidly, Somatropin, sophisticated, specialist, spherical, spill, spinal, spine, spite, sq, Staehelin, staffing, Stanley, staphylococcal, steady, Stockpile, stockpiling, strain, streamlining, subsidy, Succinate, superficial, supplementsBoost, supranational, surface, surveillance, suspected, suspended, synergistic, synthase, syringe, Tasigna, TBE, tentatively, theBetaseron, theClear, theFluvirin, Themed, theSandostatinfamily, tick, tifacogin, TIP, toAurograbandMycograb, TOBI, tobramycin, toLamisil, tough, tradenameReclast, traditional, transmitted, turnaround, unchanged, unconditional, undefined, underestimated, undergone, underground, underperformance, unexpectedly, unpredictable, untreated, upcoming, upgrade, vaccineFluvirin, vaccineQuinvaxem, vaginal, Valencia, valopicitabine, Valor, vCJD, Venezuela, viable, Village, VisionNIGHT, vital, vomiting, wage, Wellauer, West, whileEmselex, wholesome, whooping, Winterthur, withAlbuferon, withPrexige, withXyotax, witnessed, witnessing, workforce, XOMA, Xyotax, Zofran
Removed:
abandoned, accident, accidental, accumulation, aggravate, agrochemical, allegedly, altered, amid, amortize, amyotrophic, andEmselex, antihypertensive, APB, Apotex, arriving, bagged, Bayer, bench, benzodiazepine, Bielefeld, blast, bleeding, Brauerei, Burlington, cap, cathepsin, cereal, chemoattractant, CHIR, Clara, clinician, Compact, complementNeoral, complicate, conclusion, Congressional, consolidate, contraindicated, contributor, convergence, converting, cooperating, coordinate, CPAC, Crop, crucial, cultivating, dairy, Darier, Dayton, del, dependence, discontinued, discounting, enforcement, enlargement, Epstein, era, Essen, Ethiopia, exert, existence, expatriate, expose, fit, forDiovan, forLotrel, foster, founded, fruit, fueled, Gamble, GEP, GERD, GI, globalization, Graz, guideline, hard, harming, Hentsch, histone, HR, Hytrin, Iberia, inducement, industrialized, Inland, inquiry, insignificant, intensified, Interactive, intergovernmental, Ivax, Justice, Krombach, Krombacher, leave, Lek, LEPO, LIFO, ligand, LLC, Lombard, maleate, marketForadil, MD, mealtime, microtubule, military, mitochondrial, monocyte, Montenegro, Myelo, nameCombipatch, neuropathic, Neuropathy, night, NJ, noncompliance, nurture, OctreoTher, Odier, Oetker, ointment, Optico, Originated, oversee, Pacific, permissible, PhD, phenylpropanolamine, philology, physical, pigmentosa, pioneering, plaintiff, plastic, PMDEC, Pont, Portugal, pose, post, prefecture, preference, print, Procter, Prof, prohibited, projection, prudent, psychiatric, pump, Purdue, recruit, Reddy, redeemed, redefining, refractive, refuse, repeated, requesting, restatement, restructure, restructured, retainer, reuse, revealed, safer, Saline, Santa, saving, Schmidt, Serbia, sharing, showing, SkyePharma, SMON, soft, software, Son, spun, stabilizer, steroid, strength, strike, Subacute, subjectively, surgical, Sweden, TDS, teacher, technologically, Telekom, tension, terrorist, Teva, toxic, twelfth, umbrella, uncollectable, unregulated, unstable, utility, vegetable, Vermont, Vienna, violation, volatile, Voyan, waste, Watson, weaker, whichever, wholly, withLotrel, wrote, Yamanouchi, Zeneca
Filing tables
Filing exhibits
NVS similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
CERTIFICATION OF RAYMUND BREU, CHIEF FINANCIAL OFFICER OF NOVARTIS AG,
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Novartis AG (the "Company") on Form 20-F for the year ended December 31, 2006, as filed with the Securities and Exchange Commission on the date hereof (the "Annual Report"), the undersigned officer of the Company hereby certifies that to the best of such officer's knowledge:
- 1.
- The Annual Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
- 2.
- The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
By: | /s/ RAYMUND BREU | ||
Name: | Raymund Breu | ||
Title: | Chief Financial Officer | ||
Date: January 31, 2007 |
CERTIFICATION OF RAYMUND BREU, CHIEF FINANCIAL OFFICER OF NOVARTIS AG, PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002